Next Article in Journal
Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges
Next Article in Special Issue
A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine
Previous Article in Journal
Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya
Previous Article in Special Issue
Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses
 
 
Article

Article Versions Notes

Vaccines 2021, 9(8), 937; https://doi.org/10.3390/vaccines9080937
Action Date Notes Link
article pdf uploaded. 23 August 2021 21:00 CEST Version of Record https://www.mdpi.com/2076-393X/9/8/937/pdf-vor
article xml file uploaded 25 August 2021 04:09 CEST Original file -
article xml uploaded. 25 August 2021 04:09 CEST Update https://www.mdpi.com/2076-393X/9/8/937/xml
article pdf uploaded. 25 August 2021 04:09 CEST Updated version of record https://www.mdpi.com/2076-393X/9/8/937/pdf
article html file updated 25 August 2021 04:10 CEST Original file -
article html file updated 28 July 2022 07:27 CEST Update https://www.mdpi.com/2076-393X/9/8/937/html
Back to TopTop